Filing Details
- Accession Number:
- 0001209191-18-003986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-17 16:46:10
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-01-17 16:46:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 56,250 shares | Avg. Price: $156.99 | Total Value: $8,830,754.77 |
| Number of Shares After Transactions: | 49,761 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-16 | 23,813 | $155.77 | 82,198 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 11,767 | $156.63 | 70,431 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 6,130 | $157.71 | 64,301 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 10,585 | $158.82 | 53,716 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 3,955 | $159.41 | 49,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.19 to $156.17).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $156.63 (range $156.19 to $157.18).
- Open market sales reported on this line occurred at a weighted average price of $157.71 (range $157.20 to $158.19).
- Open market sales reported on this line occurred at a weighted average price of $158.82 (range $158.21 to $159.20).
- Open market sales reported on this line occurred at a weighted average price of $159.41 (range $159.21 to $159.65).
Billionaire Hedge Funds
